San Diego, CA, United States of America

Scott Stim


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Scott Stim in Autoimmune Research

Introduction

Scott Stim is an accomplished inventor based in San Diego, California, known for his contributions to the field of pharmacology and autoimmune disorder treatments. With one patent to his name, he has made significant strides in developing innovative solutions for various inflammatory conditions.

Latest Patents

Scott's patent focuses on "Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives," which are particularly promising in treating autoimmune and inflammatory disorders. The invention describes certain derivatives and pharmaceutically acceptable salts that exhibit beneficial pharmacological properties, specifically as agonists of the S1P1 receptor. These derivatives have potential applications in treating serious conditions such as psoriasis, rheumatoid arthritis, Crohn's disease, transplant rejection, multiple sclerosis, systemic lupus erythematosus, ulcerative colitis, type I diabetes, acne, and various microbial and viral infections.

Career Highlights

Scott Stim is affiliated with Arena Pharmaceuticals, Inc., a biotech company renowned for its focus on discovering and developing innovative therapeutics for serious diseases. His work at Arena Pharmaceuticals demonstrates his commitment to advancing the understanding and treatment of complex autoimmune disorders.

Collaborations

Throughout his career, Scott has collaborated with several distinguished colleagues, including Robert M. Jones and Daniel J. Buzard. These partnerships highlight the collaborative efforts within the research community, contributing to the advancement of therapeutic innovations and better patient outcomes.

Conclusion

Scott Stim's innovations in the pharmaceutical field represent a critical step towards new treatments for autoimmune and inflammatory disorders. His dedication to research and development at Arena Pharmaceuticals positions him as a key figure in the ongoing battle against these challenging medical conditions. Through his patent and collaborative efforts, Stim continues to pave the way for future innovations that promise to significantly improve patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…